PAA 7.69% 21.0¢ pharmaust limited

FDA Application for Orphan Drug Designation , PAA, MPL, page-57

  1. 451 Posts.
    lightbulb Created with Sketch. 85
    This is a forum for TALK so people can talk about what ever they want. You are now hanging to MND if that does not eventuate? the trail of talk from the BOD over 10 years will have been all for nothing. Patents aren't worth a cent unless they are monetised. In my 10 year plus PAA journey I have only seen dilution and erosion. Oh but should I not talk about that and just talk about the hard work being done on MND.

    At one stage we hoped Epichem could make PAA cost neutral and at least the BOD would use that for their wages but no at the moment the shareholders are the cash cow for this personal research company.

    Until they do something that shifts the SP needle I remain skeptical. This was meant to be a 10 year path to repurpose a drug for canine and human cancer which would be faster to approve as it is already existed. Now it is a path to MND and that is likely the last hope.

    While I disagree with class actions etc if people want to talk about it this is free chat area. You are not the chat police here on anything negative to PAA.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
0.015(7.69%)
Mkt cap ! $93.45M
Open High Low Value Volume
20.0¢ 21.5¢ 19.5¢ $459.0K 2.222M

Buyers (Bids)

No. Vol. Price($)
2 103700 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 127225 3
View Market Depth
Last trade - 16.10pm 11/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.